Amicus Therapeutics's three largest insider shareholders as of April 17, 2026 are Bradley L Campbell (President And Ceo, 998.68K shares), John F Crowley (Executive Chairman, 573.48K shares), Ellen Rosenberg (Chief Legal Officer, 464.60K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Bradley L Campbell | President And Ceo | 998,680 | 0 | 04 Mar, 2026 |
| John F Crowley | Executive Chairman | 573,478 | 0 | 05 Mar, 2024 |
| Ellen Rosenberg | Chief Legal Officer | 464,601 | 0 | 06 Jan, 2026 |
| Jeff Castelli | Chief Development Officer | 409,311 | 0 | 06 Jan, 2026 |
| Daphne Quimi | Chief Financial Officer | 398,532 | 0 | 19 Jan, 2023 |
| David Michael Clark | Chief People Officer | 221,811 | 0 | 06 Jan, 2026 |
| Simon N.R. Harford | Chief Financial Officer | 143,595 | 0 | 30 Dec, 2025 |
| Samantha Prout | Chief Accounting Officer | 125,951 | 0 | 06 Jan, 2026 |
| Burke W Whitman | - | 118,598 | 0 | 06 Jun, 2025 |
| Michael Raab | - | 115,857 | 0 | 06 Jun, 2025 |
| Glenn Sblendorio | - | 115,857 | 0 | 06 Jun, 2025 |
| Lynn Dorsey Bleil | - | 113,941 | 0 | 06 Jun, 2025 |
| Margaret G Mcglynn | - | 91,550 | 0 | 06 Jun, 2025 |
| Craig A Wheeler | - | 84,631 | 0 | 06 Jun, 2025 |
| Eiry Roberts | - | 76,275 | 0 | 06 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Mar, 2026 | Bradley L Campbell | Common Stock | D | 22,500 | $14.35 | 998,680 | D | S |
| 20 Jan, 2026 | Bradley L Campbell | Common Stock | A | 75,000 | $6.10 | 1,096,180 | D | M |
| 20 Jan, 2026 | Bradley L Campbell | Common Stock | D | 75,000 | $14.31 | 1,021,180 | D | S |
| 20 Jan, 2026 | Bradley L Campbell | Stock Options (right to buy) | D | 75,000 | $0.00 | 0 | D | M |
| 02 Jan, 2026 | David Michael Clark | Common Stock | D | 5,381 | $14.27 | 240,309 | D | F |
| 02 Jan, 2026 | Ellen Rosenberg | Common Stock | D | 13,426 | $14.27 | 494,284 | D | F |
| 02 Jan, 2026 | Samantha Prout | Common Stock | D | 3,443 | $14.27 | 138,191 | D | F |
| 02 Jan, 2026 | Jeff Castelli | Common Stock | D | 6,905 | $14.27 | 432,413 | D | F |
| 03 Jan, 2026 | Jeff Castelli | Common Stock | D | 23,102 | $14.27 | 409,311 | D | F |
| 03 Jan, 2026 | Ellen Rosenberg | Common Stock | D | 29,683 | $14.27 | 464,601 | D | F |
| 03 Jan, 2026 | Samantha Prout | Common Stock | D | 12,240 | $14.27 | 125,951 | D | F |
| 03 Jan, 2026 | David Michael Clark | Common Stock | D | 18,498 | $14.27 | 221,811 | D | F |
| 26 Dec, 2025 | Bradley L Campbell | Common Stock | D | 108,602 | $14.25 | 1,021,180 | D | F |
| 26 Dec, 2025 | Simon N.R. Harford | Common Stock | D | 71,303 | $14.25 | 143,595 | D | F |
| 19 Dec, 2025 | David Michael Clark | Common Stock | D | 25,642 | $14.17 | 245,690 | D | S |
| 15 Dec, 2025 | David Michael Clark | Common Stock | D | 25,643 | $11.00 | 271,332 | D | S |
| 15 Dec, 2025 | Bradley L Campbell | Common Stock | A | 70,426 | $9.03 | 1,207,708 | D | M |
| 15 Dec, 2025 | Bradley L Campbell | Common Stock | D | 77,926 | $10.86 | 1,129,782 | D | S |
| 15 Dec, 2025 | Bradley L Campbell | Stock Options (right to buy) | D | 70,426 | $0.00 | 0 | D | M |
| 01 Dec, 2025 | Bradley L Campbell | Common Stock | A | 14,587 | $9.03 | 1,151,869 | D | M |